Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 12Carcinoma, Non-Small-Cell Lung 4Hodgkin Disease 3Triple Negative Breast Neoplasms 2Rhabdomyosarcoma 2Recurrence 2Neoplasms 2Advanced Breast Cancer 2Neoplasm Metastasis 1NSCLC 1Metastatic HER2-positive Breast Cancer 1Lung Neoplasms 1HER2-positive Advanced Breast Cancer 1HER2-negative Breast Cancer 1Fludzoparib" and Anti-angiogenic 1Carcinoma, Squamous Cell 1Carcinoma, Large Cell 1Adenocarcinoma 1

Interventions

Fulvestrant 4trastuzumab deruxtecan 2elacestrant 2Vinorelbine 2AZD9833 2toripalimab 1talazoparib 1ribociclib 1pyrotinib 1palbociclib 1olaparib 1exemestane 1eribulin 1disitamab vedotin 1dalpiciclib 1apatinib 1abemaciclib 1Selective Estrogen Receptor Modulators 1Radiotherapy 1RAD1901 1Letrozole 1Injections 1Gonadotropin-Releasing Hormone 1Everolimus 1Capecitabine 1Aromatase Inhibitors 1Anastrozole 1AZD5305 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Advanced Breast Cancer × Vinorelbine × Clear all
NCT06500494 2025-07-24

VINOREAL

Pierre Fabre Medicament

Recruiting
368 enrolled
Breast

Advanced Breast Cancer

NCT06176534 2024-08-20

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase â…¡ Clinical Trial

Henan Cancer Hospital

Phase 2 Recruiting
240 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡